More drug companies lowered list prices for insulin this week. NPR’s Scott Simon speaks with Kaiser Health News reporter Bram Sable-Smith about what that means for patients.
NPR transcripts are created on a rush deadline by an NPR contractor. This text may not be in its final form and may be updated or revised in the future. Accuracy and availability may vary. The authoritative record of NPR’s programming is the audio record.